BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27132514)

  • 1. Leukemic survival factor SALL4 contributes to defective DNA damage repair.
    Wang F; Gao C; Lu J; Tatetsu H; Williams DA; Müller LU; Cui W; Chai L
    Oncogene; 2016 Nov; 35(47):6087-6095. PubMed ID: 27132514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.
    Ma Y; Cui W; Yang J; Qu J; Di C; Amin HM; Lai R; Ritz J; Krause DS; Chai L
    Blood; 2006 Oct; 108(8):2726-35. PubMed ID: 16763212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.
    Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L
    J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner.
    Milanovich S; Peterson J; Allred J; Stelloh C; Rajasekaran K; Fisher J; Duncan SA; Malarkannan S; Rao S
    Exp Hematol; 2015 Jan; 43(1):53-64.e1-8. PubMed ID: 25246269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
    Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
    J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia.
    Guirguis AA; Slape CI; Failla LM; Saw J; Tremblay CS; Powell DR; Rossello F; Wei A; Strasser A; Curtis DJ
    Cell Death Differ; 2016 Jun; 23(6):1049-59. PubMed ID: 26742432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes.
    Shuai X; Zhou D; Shen T; Wu Y; Zhang J; Wang X; Li Q
    Cancer Genet Cytogenet; 2009 Oct; 194(2):119-24. PubMed ID: 19781444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.
    Yang J; Chai L; Liu F; Fink LM; Lin P; Silberstein LE; Amin HM; Ward DC; Ma Y
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10494-9. PubMed ID: 17557835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
    Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
    Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4.
    Yang J; Aguila JR; Alipio Z; Lai R; Fink LM; Ma Y
    J Hematol Oncol; 2011 Sep; 4():38. PubMed ID: 21943195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
    Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
    Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of fetal hematopoietic stem cell function in the absence of Fancd2.
    Suzuki S; Racine RR; Manalo NA; Cantor SB; Raffel GD
    Exp Hematol; 2017 Apr; 48():79-86. PubMed ID: 27915139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
    Schinke C; Giricz O; Li W; Shastri A; Gordon S; Barreyro L; Bhagat T; Bhattacharyya S; Ramachandra N; Bartenstein M; Pellagatti A; Boultwood J; Wickrema A; Yu Y; Will B; Wei S; Steidl U; Verma A
    Blood; 2015 May; 125(20):3144-52. PubMed ID: 25810490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes.
    Thol F; Yun H; Sonntag AK; Damm F; Weissinger EM; Krauter J; Wagner K; Morgan M; Wichmann M; Göhring G; Bug G; Ottmann O; Hofmann WK; Schambach A; Schlegelberger B; Haferlach T; Bowen D; Mills K; Ganser A; Heuser M
    Ann Hematol; 2012 Aug; 91(8):1221-33. PubMed ID: 22488406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias.
    Popp HD; Naumann N; Brendel S; Henzler T; Weiss C; Hofmann WK; Fabarius A
    Leuk Res; 2017 Jun; 57():112-118. PubMed ID: 28359030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells.
    Satoh Y; Matsumura I; Tanaka H; Harada H; Harada Y; Matsui K; Shibata M; Mizuki M; Kanakura Y
    Leukemia; 2012 Feb; 26(2):303-11. PubMed ID: 21836608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?
    Rassool FV; Gaymes TJ; Omidvar N; Brady N; Beurlet S; Pla M; Reboul M; Lea N; Chomienne C; Thomas NS; Mufti GJ; Padua RA
    Cancer Res; 2007 Sep; 67(18):8762-71. PubMed ID: 17875717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila homologs of FANCD2 and FANCL function in DNA repair.
    Marek LR; Bale AE
    DNA Repair (Amst); 2006 Nov; 5(11):1317-26. PubMed ID: 16860002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.